Generic prescriptions can vary in amount and potency by up to 40%; 20% under or 20% over stated mg dose. With some meds, this makes little difference, but makes a huge difference in others. Insurance companies and government programs force the patient on a trial of frequently substandard generics prior to approving the patient to get brand meds. Then they make the copay so high, the patient is unable to afford it. Big pharma should be in freemarket competition with competitors to bring prices down direct to patient without insurance kickbacks called, “rebates,” to be favorably listed on insurance formulary menus. Until generics are more exact, brands are held to higher standards and frequently better.
Best wishes for good health,
Craig M. Wax, DO
Family physician, Editorial Board of Medical Economics
Host of Your Health Matters
Rowan Radio 89.7 WGLS FM
Independent Physicians For Patient independence @IP4PI